Nimmi Ramanujam | |
---|---|
Education | University of Texas at Austin (PhD) |
Known for | Inventing the pocket colposcope and callascope
Cancer screening technology WISH Revolution program Design-based STEM program, Ignite The Invisible Organ arts and storytelling initiative |
Awards | Fellow of the American Institute for Medical and Biological Engineering, Optica, Society of Photo-Optical Instrumentation Engineers, National Academy of Inventors, and Fulbright Program. 2003 TR100 Award (MIT), 2005 Global Indus Technovator Award (MIT), 2005 Era of Hope Scholar Award (DOD), 2011 Stansell Research Award (Duke University), 2018 Emerging Leader Award (Consortium of Universities for Global Health), 2019 WIMIN Leadership Award (World Molecular Imaging Congress), 2019 Social Impact Abie Award (AnitaB.org),[1] 2020 Michael S. Feld Biophotonics Award (Optica), 2020 SPIE Biophotonics Technology Innovator Award (SPIE),[2] 2023 IEEE Biomedical Engineering Award (IEEE)[3] |
Scientific career | |
Fields | Biomedical engineering Biophotonics Women's cancers Global health Engineering Design |
Institutions | Duke University |
Website | bme dukegwht |
Nirmala (Nimmi) Ramanujam[4] is an educator, innovator, and entrepreneur.[5] Ramanujam is recognized for creating globally accessible technologies for women’s health related to cancer screening, diagnosis, and treatment. She is the Robert W. Carr Professor of Engineering and Professor of Cancer Pharmacology and Global Health at Duke University.[6] She founded the Center for Global Women’s Health Technologies (GWHT) in 2013 to catalyze impactful research, educational and community outreach activities that promote women’s health.[6] In 2023, she won the IEEE Biomedical Engineering Technical Field Award, given annually for outstanding contributions to the field of Biomedical engineering.[7] In 2019, she received the social impact Abie Award for making a positive impact on women, technology, and society.[8] She was elected as a fellow of the National Academy of Inventors in 2017.[9] She founded Calla Health to commercialize technologies developed at the center. Further she has created a number of initiatives and consortia including WISH, (In)visible Organ and IGNITE to have far reaching impact in cervical cancer, reproductive health and engineering design education, respectively.